Company Filing History:
6 out of 24 
6 out of 155 
Years Active: 1992-1998
Title: **Robert D. Sindelar: A Pioneer in Immunosuppressive Compounds**
Introduction
Robert D. Sindelar, hailing from Oxford, MS, is an accomplished inventor with a noteworthy portfolio of six patents. His groundbreaking work focuses on developing compounds that inhibit complement and suppress immune activity, paving the way for innovative therapeutic solutions.
Latest Patents
Among his latest innovations, Sindelar has created compounds designed to suppress immune responses and selectively inhibit complement. These compounds, characterized by their aromatic rings and substituted dihydrobenzofurans, including spirobenzofuran-2(3H)-cycloalkanes and their open chain intermediates, exhibit significant immunosuppressive activities. The therapeutic utility of these compounds lies in their ability to interrupt the proteolytic processing of C5 into bioactive components, contributing to the amelioration of diseases and disorders mediated by complement and immune activity.
Career Highlights
Sindelar’s career has seen him associated with esteemed organizations such as T Cell Sciences, Inc. and the University of Mississippi. His work in these institutions reflects his commitment to advancing the field of immunology through novel inventions.
Collaborations
Throughout his professional journey, Sindelar has collaborated with notable individuals, including Barton J. Bradbury and Stephen H. Ip. These collaborations have enriched his research and contributed to the success of his inventions.
Conclusion
Robert D. Sindelar stands out as a significant figure in the realm of pharmaceutical innovations. His contributions in developing compounds that may quell immune responses showcase not only his inventive spirit but also the potential impact of his work on future therapeutic strategies.